Used as a chiral building block in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other bioactive molecules. Its structure incorporates both a fluorenylmethoxycarbonyl (Fmoc) protecting group and a trifluoromethyl-substituted aryl moiety, making it valuable in solid-phase peptide synthesis and medicinal chemistry. The presence of the stereocenter allows for enantioselective synthesis, enabling the production of optically pure drugs. Commonly employed in research settings for designing enzyme inhibitors and studying structure-activity relationships in drug candidates.